The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study

Background: Improving medication appropriateness is a priority of French national campaigns in nursing homes. A pilot study was conducted to evaluate the impact of a medication review in a French nursing home with a 3-month follow up. Method: A medication review was conducted in 2015 using version 2...

Full description

Bibliographic Details
Main Authors: Marie-Line Gaubert-Dahan, Abdellatif Sebouai, Wafaa Tourid, Francis Fauvelle, Raoul Aikpa, Dominique Bonnet-Zamponi
Format: Article
Language:English
Published: SAGE Publishing 2019-06-01
Series:Therapeutic Advances in Drug Safety
Online Access:https://doi.org/10.1177/2042098619855535
id doaj-0afb63b6fc714e4e903d979c07501784
record_format Article
spelling doaj-0afb63b6fc714e4e903d979c075017842020-11-25T02:52:30ZengSAGE PublishingTherapeutic Advances in Drug Safety2042-09942019-06-011010.1177/2042098619855535The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up studyMarie-Line Gaubert-DahanAbdellatif SebouaiWafaa TouridFrancis FauvelleRaoul AikpaDominique Bonnet-ZamponiBackground: Improving medication appropriateness is a priority of French national campaigns in nursing homes. A pilot study was conducted to evaluate the impact of a medication review in a French nursing home with a 3-month follow up. Method: A medication review was conducted in 2015 using version 2 STOPP and START criteria. The number and type of drugs meeting a STOPP that were reintroduced and the number and type of drug meeting a START that were stopped during follow up were measured. An expert committee adjudicated whether 3-month hospitalizations and deaths were related to medication review. The impact of medication review on the cost related to drug consumption was calculated for 3 months. Results: The 52 residents (age 84 ± 9 years, 83% female) fulfilled, on average, 2 ± 1.4 of the STOPP criteria and 0.7 ± 0.6 of the START criteria. A total of 101 drugs were stopped and 34 drugs were started. Five deaths occurred during follow up and were judged as not related to medication review. Five drugs stopped were reintroduced in five residents for a rebound effect or a symptom occurrence and one resident had stopped a START medication (aspirin) for a minor adverse drug reaction. At 3 months, a gain of 20.21 ± 31.34 euros per resident was observed. Conclusion: The medication review using version 2 STOPP and START criteria and involving the physician in charge seems useful for detecting and correcting inappropriate prescribing in a nursing home.https://doi.org/10.1177/2042098619855535
collection DOAJ
language English
format Article
sources DOAJ
author Marie-Line Gaubert-Dahan
Abdellatif Sebouai
Wafaa Tourid
Francis Fauvelle
Raoul Aikpa
Dominique Bonnet-Zamponi
spellingShingle Marie-Line Gaubert-Dahan
Abdellatif Sebouai
Wafaa Tourid
Francis Fauvelle
Raoul Aikpa
Dominique Bonnet-Zamponi
The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study
Therapeutic Advances in Drug Safety
author_facet Marie-Line Gaubert-Dahan
Abdellatif Sebouai
Wafaa Tourid
Francis Fauvelle
Raoul Aikpa
Dominique Bonnet-Zamponi
author_sort Marie-Line Gaubert-Dahan
title The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study
title_short The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study
title_full The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study
title_fullStr The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study
title_full_unstemmed The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study
title_sort impact of medication review with version 2 stopp (screening tool of older person’s prescriptions) and start (screening tool to alert doctors to right treatment) criteria in a french nursing home: a 3-month follow-up study
publisher SAGE Publishing
series Therapeutic Advances in Drug Safety
issn 2042-0994
publishDate 2019-06-01
description Background: Improving medication appropriateness is a priority of French national campaigns in nursing homes. A pilot study was conducted to evaluate the impact of a medication review in a French nursing home with a 3-month follow up. Method: A medication review was conducted in 2015 using version 2 STOPP and START criteria. The number and type of drugs meeting a STOPP that were reintroduced and the number and type of drug meeting a START that were stopped during follow up were measured. An expert committee adjudicated whether 3-month hospitalizations and deaths were related to medication review. The impact of medication review on the cost related to drug consumption was calculated for 3 months. Results: The 52 residents (age 84 ± 9 years, 83% female) fulfilled, on average, 2 ± 1.4 of the STOPP criteria and 0.7 ± 0.6 of the START criteria. A total of 101 drugs were stopped and 34 drugs were started. Five deaths occurred during follow up and were judged as not related to medication review. Five drugs stopped were reintroduced in five residents for a rebound effect or a symptom occurrence and one resident had stopped a START medication (aspirin) for a minor adverse drug reaction. At 3 months, a gain of 20.21 ± 31.34 euros per resident was observed. Conclusion: The medication review using version 2 STOPP and START criteria and involving the physician in charge seems useful for detecting and correcting inappropriate prescribing in a nursing home.
url https://doi.org/10.1177/2042098619855535
work_keys_str_mv AT marielinegaubertdahan theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT abdellatifsebouai theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT wafaatourid theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT francisfauvelle theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT raoulaikpa theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT dominiquebonnetzamponi theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT marielinegaubertdahan impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT abdellatifsebouai impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT wafaatourid impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT francisfauvelle impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT raoulaikpa impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
AT dominiquebonnetzamponi impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy
_version_ 1724729584153264128